Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Hospira
Hospira
Activities:
Drug Delivery
Pharmaceutical
A global specialty pharmaceutical and medication delivery company.
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
FDA cautions Pfizer subsidiary in India in quality control warning letter
The letter is the result of an inspection at Hospira Healthcare India that identified GMP violations in quality control, data integrity, and microbial control
Drug Delivery
Mylan and Hospira voluntarily recall injectables
Glass and copper salts were found in the companies’ injectable medications but no adverse reactions have been reported as yet
Regulatory
Brussels explains why it approved Pfizer/Hospira deal
Pfizer made a commitment to remove possible product overlaps between the two companies
Regulatory
Hospira calls for biosimilars to have same name as biologicals
Different names for a biologic and the biosimilar medicine patterned on that biologic could create confusion among clinicians
Research & Development
Hospira and Pfenex link up to develop Lucentis biosimilar
Pfenex will receive US$51m upfront once the collaboration receives antitrust approval
Drug Delivery
Pfizer to acquire Hospira
Pfizer and Hospira have entered into a definitive merger agreement under which Pfizer will acquire Hospira
Manufacturing
Opinion: Still not getting it right
The future for pharma development is bright, but there are still too many potentially dangerous recalls in the manufacturing sector
Subscribe now